NO20055227L - Stamceller med okt sensitivitet for en kjemoattraktant og fremgangsmater for fremstilling og anvendelse derav - Google Patents

Stamceller med okt sensitivitet for en kjemoattraktant og fremgangsmater for fremstilling og anvendelse derav

Info

Publication number
NO20055227L
NO20055227L NO20055227A NO20055227A NO20055227L NO 20055227 L NO20055227 L NO 20055227L NO 20055227 A NO20055227 A NO 20055227A NO 20055227 A NO20055227 A NO 20055227A NO 20055227 L NO20055227 L NO 20055227L
Authority
NO
Norway
Prior art keywords
chemoattractant
methods
stem cells
increased sensitivity
preparation
Prior art date
Application number
NO20055227A
Other languages
English (en)
Norwegian (no)
Inventor
Tsvee Lapidot
Orit Kollet
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL15530303A external-priority patent/IL155303A0/xx
Priority claimed from IL15930703A external-priority patent/IL159307A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO20055227L publication Critical patent/NO20055227L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/12—Hepatocyte growth factor [HGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20055227A 2003-04-08 2005-11-07 Stamceller med okt sensitivitet for en kjemoattraktant og fremgangsmater for fremstilling og anvendelse derav NO20055227L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL15530303A IL155303A0 (en) 2003-04-08 2003-04-08 Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
IL15930703A IL159307A0 (en) 2003-12-10 2003-12-10 Stem cells having increased sensitivity to a chemo-attractant and methods of generating and using same
PCT/IL2004/000315 WO2004090121A2 (fr) 2003-04-08 2004-04-07 Cellules souches presentant une sensibilite accrue a un agent chimio-attractif, methodes de production et d'utilisation associees

Publications (1)

Publication Number Publication Date
NO20055227L true NO20055227L (no) 2005-11-07

Family

ID=33161264

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055227A NO20055227L (no) 2003-04-08 2005-11-07 Stamceller med okt sensitivitet for en kjemoattraktant og fremgangsmater for fremstilling og anvendelse derav

Country Status (8)

Country Link
US (1) US8029780B2 (fr)
EP (1) EP1613742A2 (fr)
JP (2) JP4865541B2 (fr)
AU (1) AU2004227205B2 (fr)
CA (1) CA2519975C (fr)
IL (2) IL171254A (fr)
NO (1) NO20055227L (fr)
WO (1) WO2004090121A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX373998B (es) 2006-03-24 2020-07-22 Childrens Medical Center Uso de un modulador de células madre hematopoyeticas (hsc) para promover el crecimiento de hsc.
EP3824885A1 (fr) 2006-10-20 2021-05-26 Children's Medical Center Corporation Procédé pour améliorer la régénération tissulaire
EP2094839B1 (fr) 2006-12-08 2020-02-05 University of Rochester Expansion de cellules souches hématopoïétiques
WO2009134532A2 (fr) * 2008-03-07 2009-11-05 The Trustees Of Columbia University In The City Of New York Homing dans des cellules souches mésenchymateuses
EP3031907B1 (fr) 2008-11-06 2021-01-06 Indiana University Research and Technology Corporation Matériaux et procédés améliorant les protocoles de prise de greffe de cellules souches hématopoïétiques
EP3269802B1 (fr) 2011-09-30 2019-10-23 Bluebird Bio, Inc. Composés permettant d'améliorer la transduction virale
PT2785834T (pt) * 2011-12-02 2020-11-13 Fate Therapeutics Inc Composição de células estaminais melhorada
US10162168B2 (en) 2013-05-03 2018-12-25 Wilcox Industries Corp. Binocular bridge for thermal viewing device
EP3413896B1 (fr) 2016-02-12 2021-03-17 Bluebird Bio, Inc. Compositions d'augmentation de vcn et ses procédés d'utilisation
RU2021103425A (ru) 2016-02-12 2021-02-25 Блубёрд Био, Инк. Композиции, повышающие число копий вектора (чкв), и способы их применения

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622853A (en) * 1990-05-01 1997-04-22 Becton Dickinson And Company T lymphocyte precursor
JP3395181B2 (ja) * 1991-07-26 2003-04-07 東レ株式会社 造血幹細胞増加剤
DE4422667A1 (de) * 1994-06-30 1996-01-04 Boehringer Ingelheim Int Verfahren zur Herstellung und Züchtung hämatopoetischer Vorläuferzellen
IT1271088B (it) * 1994-11-24 1997-05-26 Dompe Spa Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche
KR100765687B1 (ko) * 1995-08-29 2007-10-11 안제스에무지 가부시키가이샤 Ｈｇｆ 유전자를 함유하는 약제
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
CA2304961A1 (fr) * 1997-09-25 1999-04-01 Glycotech Corporation Procedes et compositions utilises pour lier des cellules souches hematopoietiques
JP3962459B2 (ja) * 1997-10-28 2007-08-22 麒麟麦酒株式会社 造血幹細胞の分化・増殖調節方法
AU4323599A (en) * 1998-05-29 1999-12-13 Instituto Superiore Di Sanita Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
IL125532A0 (en) 1998-07-27 1999-03-12 Yeda Res & Dev Hematopoietic cell composition for use in transplantation
US6642049B1 (en) * 1998-12-04 2003-11-04 The United States Of America As Represented By The Secretary Of The Navy Human brain endothelial cells and growth medium and method for expansion of primitive CD34+CD38-bone marrow stem cells
WO2000046349A1 (fr) * 1999-02-04 2000-08-10 Technion Research & Development Foundation Ltd. Methode et appareil de renouvellement et de multiplication de cellules souches hematopoietiques et/ou de progeniteurs
WO2002016556A1 (fr) * 2000-08-25 2002-02-28 Asahi Kasei Kabushiki Kaisha Milieu de culture de cellule souche et procede de culture utilisant ce milieu
GB0031390D0 (en) * 2000-12-21 2001-02-07 Imp College Innovations Ltd Methods
JP2004526449A (ja) * 2001-03-29 2004-09-02 イクシオン・バイオテクノロジー・インコーポレーテッド 非膵性幹細胞の膵分化経路への分化転換法
CN1553963A (zh) * 2001-07-10 2004-12-08 ǿ����ǿ���о����޹�˾ 用于遗传修饰造血祖细胞的方法和这些被修饰细胞的应用

Also Published As

Publication number Publication date
JP2006522604A (ja) 2006-10-05
CA2519975A1 (fr) 2004-10-21
AU2004227205A1 (en) 2004-10-21
WO2004090121A2 (fr) 2004-10-21
IL200207A (en) 2012-06-28
US8029780B2 (en) 2011-10-04
IL171254A0 (en) 2011-08-01
CA2519975C (fr) 2013-07-02
AU2004227205B2 (en) 2010-06-10
US20070172464A1 (en) 2007-07-26
JP4865541B2 (ja) 2012-02-01
EP1613742A2 (fr) 2006-01-11
IL200207A0 (en) 2011-08-01
WO2004090121A3 (fr) 2004-12-29
JP5362659B2 (ja) 2013-12-11
IL171254A (en) 2013-06-27
JP2010263907A (ja) 2010-11-25

Similar Documents

Publication Publication Date Title
CY1116768T1 (el) Συνθεσεις οι οποιες περιεχουν βλαστοκυτταρα θηλυκης γαμετικης σειρας και μεθοδοι χρησης αυτων
NO20080067L (no) Polypeptider som har antimikrobeaktivitet og polynukleotider som koder for disse
MX2021015070A (es) Inmunomodulacion usando celulas madre de la placenta.
NO20083153L (no) Kjemiske forbindelser
NO20055211L (no) Anti-fungale forbindelser og fremgangsmater for anvendelse
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
TW200614966A (en) Analyte monitoring system with wireless alram
NO20074853L (no) Smamolekylinhibitorer av MDM2 og anvendelser derav
NO20081013L (no) 7-substituerte aza-indazoler, sammensetninger inneholdende disse, produksjonsmetode og anvendelse derav
AR056256A1 (es) Plantas resistentes al estres
BRPI0414593A (pt) derivados de ácido sulfonamida substituìda-indol-2-carboxìlico como inibidores de pai-1
NO20083324L (no) Multisykliske aminosyrederivater og anvendelse derav
EA200701918A1 (ru) Белок липокалин
PL1926813T5 (pl) Populacje komórkowe mające aktywność immunoregulatorową, sposób izolacji i zastosowania
NO20075998L (no) Tigecyklin og metoder til fremstilling av 9-aminominocyklin
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
EP2516624A4 (fr) Lignée cellulaire 3m
NO20071840L (no) Ikke-peptid bradykininantagonister og farmasoytiske sammensetninger derav.
DK1954811T3 (da) Inducerbare ekspressionssystemer
HN2003000227A (es) Inhibidores de quinasas
NO20062695L (no) Genvarianter kodende for proteiner fra metabolsk reaksjonsveien til finkjemikalier
CY1112877T1 (el) Μεταλλαγματα αυξητικου παραγoντα υψηλης δραστικοτητας
NO20081470L (no) Polypeptider som har antimikrobeaktivitet og polynukleotider som koder for disse.
NO20061470L (no) Fremgangsmate for fremstilling av gamma-karboksylerte proteiner
NO20075227L (no) Treatment of eczemas